Rentschler Biopharma has appointed Dr. Ralf Otto as chief operating officer, effective February 1, 2018. He will be responsible for development, manufacturing and quality management.
“We are very pleased to welcome Dr. Otto to the management team of Rentschler Biopharma SE. In our industry, Dr. Otto has an excellent reputation as a thought leader and proven his expertise in strategy and corporate management. He combines extensive experience in biopharmaceutical manufacturing, outstanding industry knowledge and a substantial international network. We are looking forward to Dr. Otto's proficiency, his ideas and his personality," explained Prof. Dr. Nikolaus F. Rentschler, chairman of the Supervisory Board of Rentschler Biopharma SE.
Dr. Ralf Otto has more than 20 years experience in the biotechnology industry and management consulting. Most recently, he was a Partner at McKinsey & Company and essentially built their bio division over the past five years. Since winning the genius biotech award by the state of Baden-Württemberg, in 2001, Dr. Otto has also supported the development of local emerging biotechnology industries.